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These individual and clusters of proteins may prove to be early 
biomarkers of osteoarthritis, and potentially guide future develop- 
ment of therapeutic agents. 
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Background: Various models have been proposed for the pre- 
clinical study of generalised, non-inflammatory joint disease. The 
Hartley guinea pig is a spontaneous OA model and recently 
ovariectomy-induced, relatively mild cartilage erosions were de- 
scribed in the rat (Hoegh-Andersen et al., Arthritis Res Ther 2004; 
6:R169-R180). Biochemical markers, including fragments of type 
II collagen, have been applied for monitoring disease progres- 
sion in these preclinical models. The urinary concentration of C- 
telopeptides of type II collagen (CTX-II) is correlated to extent of 
cartilage erosion, however, collection of urine is inconvenient in 
animals, and therefore appropriate serum tests are needed to fa- 
cilitate preclinical research. 
Aim of Study: To compare the occurrence of type II collagen 
degradation in articular cartilage with the presence of collagen 
fragments in urine and serum in a novel model of ovariectomy- 
induced accelerated cartilage degradation. 
Methods: Six months old female Sprague Dawley rats were ei- 
ther ovariectomised (11 animals) or sham operated (11 animals), 
and subsequently euthanised at day 7 (4 animals from each 
group), day 14 (4 animals from each group), and day 28 (3 ani- 
mals from each group). Blood and urine samples were collected 
at baseline and weeks 2 and 4 after operation. Four non-operated 
animals served as additional controls. Immunohistological detec- 
tion of C-telopeptide fragments were performed in joint sections 
from all animals using monoclonal antibody F46 recognising the 
neo-epitope EKGPDP having a free C-terminal proline. In addi- 
tion, CTX-II was quantitatively assessed by immunoassay in the 
urine and serum specimens. 
Results: The presence of telopeptide fragments of type II colla- 
gen was observed in growth plate in all rats. However, two and 
four weeks after ovariectomy, collagen type II neo-epitopes could 
in addition be detected in the superficial zone of articular carti- 
lage. This was absent in sham operated and control animals. Both 
urine and serum CTX II demonstrated an ovariectomy-induced el- 
evation of 180-190% (both p<0.001 ) two weeks after operation. 
Conclusion: The simultaneous presence of type II collagen neo- 
epitopes, i.e. EKGPDP-containing fragments, in sections of ar- 
ticular cartilage as well as in serum and urine suggest that the 
increase in blood and urine levels of CTX-II originates from an 
increased destruction of articular cartilage in this model of accel- 
erated cartilage degradation. 
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Age-related changes in articular cartilage are likely to play a 
role in the etiology of OA. One of the major changes in the ex- 
tracellular matrix of cartilage is the age-related accumulation of 
advanced glycation end products (AGEs). Pentosidine, an AGE 
crosslink, is one of the few characterized AGEs and is consid- 
ered an adequate marker for the many AGEs that are formed in 
vivo. We used data from a longitudinal observation study to de- 
termine if pentosidine could serve as a marker to predict cartilage 
loss. 
Materials and Methods: We conducted an prospective analysis 
of data from the Boston Osteoarthritis of the Knee Study (BOKS); 
a completed natural history study of knee osteoarthritis. All sub- 
jects in the study met ACR criteria for knee OA. Knee MR im- 
ages were scored for cartilage in 14 plates of the knee using 
the WORMS semi-quantitative grading scheme. Within the BOKS 
population 127 subjects had both baseline pentosidine and longi- 
tudinal MRI measurements (MRI's performed at baseline and 30 
months later). Urinary pentosidine was assayed and normalized 
to creatinine to account for differences in urine concentrations. 
We analyzed the data using 3 different methods to assess if base- 
line measures of pentosidine predicted subsequent cartilage loss 
on MRI. These were: 1) Analysis 1- logistic regression with the 
outcome cartilage loss in any plate; 2) Analysis 2- proportional 
odds model where the outcome was defined as 0= no cartilage 
loss, 1=cartilage loss in 1 plate, 2= cartilage loss in 2 plates, and 
3= cartilage loss in at least 3 plates; and 3) Analysis 3- Poisson 
regression with the outcome the number of plates with cartilage 
loss. All analyses were adjusted for age, sex and BMI. 
Results: At baseline the mean (SD) age was 67 (9) years and 
60% were male. The results for the three analytic steps are as fol- 
lows: Analysis 1 - the odds ratio for cartilage loss is 0.996 (95%CI 
0.92- 1.07) with 1 unit increase in pentosidine. Analysis 2- the 
odds ratio for more cartilage loss is 0.993 (95%CI 0.93, 1.07) with 
1 unit increase in pentosidine. Analysis 3- The relative number of 
plates with cartilage loss decreased by 0.2% (95%CI -3% to 3%) 
with a 1 unit increase in pentosidine. 
Conclusion: Urine pentosidine does not predict knee cartilage 
loss. Previous studies have suggested that local content within 
cartilage of AGE's is elevated in persons at high risk for progres- 
sion. Our data suggest that these changes are not measurable 
systemically. Alternatively, urinary pentosidine levels reflect car- 
tilage degradation in all joints (thus whole body cartilage break- 
down) and may therefore not relate to OA severity in a single knee 
joint. 
